BriaCell Therapeutics Corp. Quarterly Liabilities, Current in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
BriaCell Therapeutics Corp. quarterly Liabilities, Current history and growth rate from Q2 2021 to Q1 2024.
  • BriaCell Therapeutics Corp. Liabilities, Current for the quarter ending April 30, 2024 was $6.76M, a 389% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $6.76M +$5.37M +389% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $3.92M +$3.25M +485% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $1.05M +$72.5K +7.44% Oct 31, 2023 10-Q 2023-12-14
Q2 2023 $1.8M +$860K +91.4% Jul 31, 2023 10-Q 2024-06-14
Q1 2023 $1.38M Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $670K Jan 31, 2023 10-Q 2023-03-16
Q3 2022 $974K Oct 31, 2022 10-Q 2022-12-14
Q2 2022 $941K +$384K +69% Jul 31, 2022 10-K 2023-10-25
Q2 2021 $557K Jul 31, 2021 10-K 2022-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.